This is a non-competitive combined synopsis/solicitation for a firm fixed price purchase order. The National Institutes of Health intends to award a contract to Seer, Inc. for LC-MS analysis of 280 processed mouse serum samples using their proprietary Proteograph Platform and Analysis Suite. Performance of services will be at Seer, Inc.'s location in Redwood City, California. No specific budget amount or submission timeline is mentioned in the description. The acquisition is not expected to exceed the simplified acquisition threshold.